Loading...
OTCM
BIIO
Market cap0kUSD
Jul 01, Last price  
0.00USD
Name

Bionovate Technologies Corp

Chart & Performance

D1W1MN
OTCM:BIIO chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
0k
22,95034,80628,8438,2494,4356,1185,3860000
Net income
-107k
L-12.70%
-17,6932,863-87,533-91,205-48,204-38,361-323,313-1,740,736-208,896-122,045-106,544
CFO
0k
L
0-64,163-56,353-15,14842910,604-1,503,305-292102-236

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Bionovate Technologies Corp. is a medical device enterprise dedicated to pioneering automated solutions for the treatment of age spots. Its core objective is to engineer a sophisticated, computer-driven system designed to precisely target and treat these blemishes on any area of the body. The firm plans to distribute these advanced systems globally, marketing them to healthcare providers and wellness centers. Founded in Cham, Switzerland, in 2010, the organization previously traded under the name MJP International Ltd. before adopting Bionovate Technologies Corp. in December 2017. Since October 7, 2020, the company has operated as an affiliated entity of Human Data AG.
IPO date
Mar 28, 2014
Employees
Domiciled in
CH
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFY
2021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT